Imprimer

Rivastigmine-L-tartrate ≥95%, solide cristallin

Fournisseur: Cayman Chemical
Danger

Synonyms: Rivastigmine tartrate, (S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate, N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate, 3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate

14270-100 14270-250 14270-1 14270-500
CAYM14270-100EA 202 EUR
CAYM14270-100 CAYM14270-250 CAYM14270-1 CAYM14270-500
Rivastigmine-L-tartrate ≥95%, solide cristallin
Rivastigmine-L-tartrate

Rivastigmine is an irreversible inhibitor of acetylcholinesterase (IC50=4,15 µm) and butyrylcholinesterase (IC50=37 nM).


It acts by covalently modifying a serine residue in the active site by carbamoylation. Rivastigmine has found use in modifying the course of neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as it stabilises or reduces the rate of decline in certain cognitive functions.

Formule: C₁₄H₂₂N₂O₂·C₄H₆O₆
Température de stockage: Congélateur
Numéro MDL: MFCD03700731
Numéro CAS: 129101-54-8

Commander maintenant


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Plus About VWR